Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Low Sodium Intake on the Anti-proteinuric Efficacy of Olmesartan in Hypertensive Patients With Albuminuria Through Open-label Randomized Trial

NCT01552954 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.

NCT NCT01552954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01552954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Low Sodium Intake on the Anti-proteinuric Efficacy of Olmesartan in Hypertensive Patients With Albuminuria Through Open-label Randomized Trial
Lead sponsor
Seoul National University Bundang Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2012
Completion date
October 31, 2013
Enrollment
269 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, hypertension, microalbuminuria